PT88415A - Diagnosis and treatment of double stranded deficiency states - Google Patents
Diagnosis and treatment of double stranded deficiency statesInfo
- Publication number
- PT88415A PT88415A PT88415A PT8841588A PT88415A PT 88415 A PT88415 A PT 88415A PT 88415 A PT88415 A PT 88415A PT 8841588 A PT8841588 A PT 8841588A PT 88415 A PT88415 A PT 88415A
- Authority
- PT
- Portugal
- Prior art keywords
- double
- dsrna
- stranded
- opt
- interferon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9352387A | 1987-09-04 | 1987-09-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT88415A true PT88415A (pt) | 1989-07-31 |
| PT88415B PT88415B (pt) | 1992-10-30 |
Family
ID=22239406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT88415A PT88415B (pt) | 1987-09-04 | 1988-09-02 | Processo para a determinacao de estados de deficiencia em pacientes de arn de dupla cadeia e para a preparacao de composicoes farmaceuticas contendo arndc para o tratamento dessas deficiencias |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPH0825884B2 (pt) |
| KR (1) | KR890005277A (pt) |
| CN (1) | CN1031651A (pt) |
| AU (3) | AU2186488A (pt) |
| CA (1) | CA1336683C (pt) |
| DK (1) | DK491088A (pt) |
| FI (1) | FI884069A (pt) |
| IL (1) | IL87664A (pt) |
| NO (1) | NO883868L (pt) |
| NZ (1) | NZ226033A (pt) |
| OA (1) | OA08911A (pt) |
| PH (1) | PH26320A (pt) |
| PT (1) | PT88415B (pt) |
| RU (1) | RU2001917C1 (pt) |
| ZA (1) | ZA886581B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088344C (zh) * | 1997-10-17 | 2002-07-31 | 青岛市卫生防疫站 | 富硒或富锌蚯蚓干粉或提取物的制造方法 |
| US20060035859A1 (en) * | 2003-05-16 | 2006-02-16 | Hemispherx Biopharma | Treating severe and acute viral infections |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4024222A (en) * | 1973-10-30 | 1977-05-17 | The Johns Hopkins University | Nucleic acid complexes |
| JPS57200310A (en) * | 1981-05-26 | 1982-12-08 | Merck & Co Inc | Local application of interferon inducer |
| AU1820388A (en) * | 1987-07-17 | 1989-01-19 | Hem Research, Inc. | Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles |
-
1988
- 1988-08-30 NO NO88883868A patent/NO883868L/no unknown
- 1988-09-01 CA CA000576351A patent/CA1336683C/en not_active Expired - Fee Related
- 1988-09-02 NZ NZ226033A patent/NZ226033A/xx unknown
- 1988-09-02 DK DK491088A patent/DK491088A/da not_active Application Discontinuation
- 1988-09-02 IL IL8766488A patent/IL87664A/en not_active IP Right Cessation
- 1988-09-02 PT PT88415A patent/PT88415B/pt not_active IP Right Cessation
- 1988-09-02 PH PH37488A patent/PH26320A/en unknown
- 1988-09-02 FI FI884069A patent/FI884069A/fi not_active IP Right Cessation
- 1988-09-02 AU AU21864/88A patent/AU2186488A/en not_active Abandoned
- 1988-09-02 RU SU884356574A patent/RU2001917C1/ru not_active IP Right Cessation
- 1988-09-03 CN CN88106411A patent/CN1031651A/zh not_active Withdrawn
- 1988-09-03 JP JP63219654A patent/JPH0825884B2/ja not_active Expired - Fee Related
- 1988-09-03 KR KR1019880011423A patent/KR890005277A/ko not_active Application Discontinuation
- 1988-09-05 OA OA59419A patent/OA08911A/xx unknown
- 1988-09-05 ZA ZA886581A patent/ZA886581B/xx unknown
-
1992
- 1992-06-03 AU AU17366/92A patent/AU1736692A/en not_active Abandoned
-
1995
- 1995-01-04 AU AU10014/95A patent/AU1001495A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR890005277A (ko) | 1989-05-13 |
| OA08911A (en) | 1989-10-31 |
| PT88415B (pt) | 1992-10-30 |
| JPH0825884B2 (ja) | 1996-03-13 |
| CA1336683C (en) | 1995-08-15 |
| DK491088D0 (da) | 1988-09-02 |
| IL87664A (en) | 1995-03-15 |
| FI884069A (fi) | 1989-03-05 |
| DK491088A (da) | 1989-03-05 |
| RU2001917C1 (ru) | 1993-10-30 |
| AU1001495A (en) | 1995-03-30 |
| AU1736692A (en) | 1992-07-30 |
| IL87664A0 (en) | 1989-02-28 |
| JPH01131118A (ja) | 1989-05-24 |
| FI884069A0 (fi) | 1988-09-02 |
| NO883868L (no) | 1989-03-06 |
| NO883868D0 (no) | 1988-08-30 |
| PH26320A (en) | 1992-04-29 |
| NZ226033A (en) | 1999-08-30 |
| ZA886581B (en) | 1989-04-26 |
| AU2186488A (en) | 1989-03-09 |
| CN1031651A (zh) | 1989-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE122402T1 (de) | Diagnose von mangelzuständen doppelsträngiger rns. | |
| Nordlund et al. | Inhibition of biologic activity of poly I: poly C by human plasma | |
| Wagner-Jauregg | The treatment of general paresis by inoculation of malaria | |
| KR910700057A (ko) | Aica리보시드 전달 및 혈당을 저하시키기 위한 방법 및 화합물 | |
| NO882853L (no) | Korreksjon med dobbeltraadet rna av unormale tilstander i immunkomplekser som er i omloep, og i monocyttfunkjon. | |
| Einhorn et al. | Interferon treatment of human malignancies-a short review | |
| SE7806232L (sv) | Sett och anordning for kvantitativ bestemning av optiskt aktiva emnen, serskilt av glukoshalten i blod, plasma eller serum | |
| PT88415A (pt) | Diagnosis and treatment of double stranded deficiency states | |
| PT91094A (pt) | Metodo de diagnostico de infeccoes virais associadas com a fadiga cronica | |
| EP1778857A1 (en) | Direct activation of atiii in whole blood and plasma | |
| ES2055314T3 (es) | Tratamiento de disfuncion leucocitaria con gm-csf. | |
| US7498130B2 (en) | Method of reducing viral load | |
| BR0212917A (pt) | Método para tratamento de infecção de vìrus da hepatite c em pacientes que não responderam a tratamento | |
| Vandeputte et al. | Influence and production of interferon in Rauscher virus infected mice | |
| HUT48029A (en) | Diagnostics and treatment of statuses of two-filament ribonucleic acid defect | |
| ATE204760T1 (de) | Verwendung von thymosin zur behandlung von hepatitis c bei patienten, die auf interferongaben nicht ansprechen | |
| EP0313005A3 (en) | Method for detecting carcinomatous and precarcinomatous colo-rectal disease | |
| JPS6479657A (en) | Vital decision of medicine | |
| BEVER JR et al. | The kinetics of interferon induction by poly ICLC in humans | |
| Wierusz‐Wysocka et al. | Influence of hemodialysis on plasma chemotactic activity and the chemotactic responsiveness of polymorphonuclear neutrophils | |
| Emås et al. | Comparison of the gastric acid responses to pentagastrin and insulin hypoglycemia in male and female ulcer patients | |
| Petrovsky et al. | Evidence for the viral aetiology of IDDM | |
| WO2023230482A3 (en) | Alu sines of the mir-498(46) cistron mediate intrinsic interferon and antiviral response in human placenta | |
| FI894592A (fi) | Diagnostisering av oeverfloedig fetma foerorsakad av genetisk foerorsakad oeferfloedig fetma. | |
| Bartal et al. | Pituitary tumors manifesting with amenorrhea-galactorrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Patent granted, date of granting |
Effective date: 19920406 |
|
| MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20041006 |